Human Toll-like receptor 4 recognizes host-specific LPS modifications
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Lipopolysaccharide (LPS) is the principal proinflammatory component of the Gram-negative bacterial envelope and is recognized by the Toll-like receptor 4 (TLR4)-MD-2 receptor complex. Bacteria can alter the acylation state of their LPS in response to environmental changes. One opportunistic bacterium, Pseudomonas aeruginosa, synthesizes more highly acylated (hexa-acylated) LPS structures during adaptation to the cystic fibrosis airway. Here we show that human, but not murine, TLR4-MD-2 recognizes this adaptation and transmits robust proinflammatory signals in response to hexa-acylated but not penta-acylated LPS from P. aeruginosa. Whereas responses to lipidIVA and taxol are dependent on murine MD-2, discrimination of P. aeruginosa LPS structures is mediated by an 82-amino-acid region of human TLR4 that is hypervariable across species. Thus, in contrast to mice, humans use TLR4 to recognize a molecular signature of bacterial-host adaptation to modulate the innate immune response.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In humans, hexa-acylated LPS potently activates TLR4 and host immunity, whereas hypo-acylated penta- and tetra-acylated LPS poorly activate TLR4 and can antagonize immune activation by hexa-acylated LPS6–9.”
From Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses (2025) · cites this paper as [8]
In the citing paper
“although the LPS response between human and mouse TLR4/MD2 has been shown to differ8”
From Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses (2025) · cites this paper as [8]
In the citing paper
“The ability of human TLR4/MD2 to discriminate LPS of distinct acylation states differs from that of mouse TLR4/MD28”
From Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses (2025) · cites this paper as [8]
In the citing paper
“Endotoxin causes inflammatory activation mainly via activating TLR4 (with co-receptor MD2) on the cell surface, resulting in NF-κB transcriptional activation of hundreds of inflammatory genes, including pro-inflammatory cytokines such as TNFα, IL-6 and pro-IL-1β [4, 17, 18].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [4]
In the citing paper
“LPS toxicity varies depending on lipid A composition, and this depends on bacterial species, strain and environmental conditions [3–5].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [4]
Citations
Cites
The Pfam Protein Families Database
Bateman, A. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.276 · Cited by 14,000
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3749 · Cited by 3,374
Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80119-3 · Cited by 3,362
MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4
Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., & Kimoto, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1777 · Cited by 2,185
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L., & Schwartz, D. A. (2000) · Nature Genetics · doi:10.1038/76048 · Cited by 2,024
Rozas, J., & Rozas, R. (1999) · Bioinformatics · doi:10.1093/bioinformatics/15.2.174 · Cited by 1,968
Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)
Qureshi, S. T., Larivière, L., Leveque, G., Clermont, S., Moore, K. J., Gros, P., & Malo, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.615 · Cited by 1,525
Receptor-Dependent Mechanisms of Cell Stimulation by Bacterial Endotoxin
Ulevitch, R. J., & Tobias, P. S. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.002253 · Cited by 1,442 · cited 1×
“; and CD14, which is a high-affinity glycosyl-phosphatidyl inositol–linked LPS-binding protei”
BackgroundThe Pfam Protein Families Database
Bateman, A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.263 · Cited by 1,256
Research works printed but not linked: 1
- Raetz, C. R. H. Bacterial lipopolysaccharides: a remarkable family of bioactive macroamphiphiles, in Escherichia coli and Salmonella (ed. Neidhardt, F. C.) 1035–1063 (ASM, Washington DC, 1996).
Cited by
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
Animal models of acute lung injury
Matute-Bello, G., Frevert, C. W., & Martin, T. R. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00010.2008 · Cited by 1,728
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling
Ciesielska, A., Matyjek, M., & Kwiatkowska, K. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03656-y · Cited by 1,420
Key roles of adjuvants in modern vaccines
Reed, S. G., Orr, M. T., & Fox, C. B. (2013) · Nature Medicine · doi:10.1038/nm.3409 · Cited by 1,419
Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans
Vatanen, T., Kostic, A. D., d’Hennezel, E., Siljander, H., Franzosa, E. A., Yassour, M., Kolde, R., Vlamakis, H., Arthur, T. D., Hämäläinen, A.-M., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.007 · Cited by 1,289
“One limitation of mouse studies is that LPS subtypes that are antagonistic or silent in humans are instead recognized as stimulatory in mice due to differences between the mouse and human LPS co-receptor MD2 (Hajjar et al., 2002).”
Crystal Structure of the TLR4-MD-2 Complex with Bound Endotoxin Antagonist Eritoran
Kim, H. M., Park, B. S., Kim, J.-I., Kim, S. E., Lee, J., Oh, S. C., Enkhbayar, P., Matsushima, N., Lee, H., Yoo, O. J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.002 · Cited by 1,177
Essential role of MD-2 in LPS responsiveness and TLR4 distribution
Nagai, Y., Akashi, S., Nagafuku, M., Ogata, M., Iwakura, Y., Akira, S., Kitamura, T., Kosugi, A., Kimoto, M., & Miyake, K. (2002) · Nature Immunology · doi:10.1038/ni809 · Cited by 1,020
LPS, TLR4 and infectious disease diversity
Miller, S. I., Ernst, R. K., & Bader, M. W. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1068 · Cited by 998
Self-citationVaure, C., & Liu, Y. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00316 · Cited by 842
“This discrimination is mediated by the 82-amino acid hypervariable region of TLR4 (44).”
BackgroundSmith, K. D., Andersen-Nissen, E., Hayashi, F., Strobe, K., Bergman, M. A., Barrett, S. L. R., Cookson, B. T., & Aderem, A. (2003) · Nature Immunology · doi:10.1038/ni1011 · Cited by 808
Pathogen–Host Interactions in Pseudomonas aeruginosa Pneumonia
Sadikot, R. T., Blackwell, T. S., Christman, J. W., & Prince, A. S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1044so · Cited by 799
Leucine-rich repeats and pathogen recognition in Toll-like receptors
Bell, J. K., Mullen, G. E. D., Leifer, C. A., Mazzoni, A., Davies, D. R., & Segal, D. M. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00242-4 · Cited by 762
Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel
Schmidt, M., Raghavan, B., Müller, V., Vogl, T., Fejer, G., Tchaptchet, S., Keck, S., Kalis, C., Nielsen, P. J., Galanos, C., et al. (2010) · Nature Immunology · doi:10.1038/ni.1919 · Cited by 593
Akira, S. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00013-4 · Cited by 584
Fujihara, M., Muroi, M., Tanamoto, K.-I., Suzuki, T., Azuma, H., & Ikeda, H. (2003) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.08.003 · Cited by 574
Klebsiella pneumoniae infection biology: living to counteract host defences
Bengoechea, J. A., & Sa Pessoa, J. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy043 · Cited by 568
Mookherjee, N., Brown, K. L., Bowdish, D. M. E., Doria, S., Falsafi, R., Hokamp, K., Roche, F. M., Mu, R., Doho, G. H., Pistolic, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2455 · Cited by 567
Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis
Needham, B. D., & Trent, M. S. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3047 · Cited by 565
“Unmodified E. coli lipid A, which contains six acyl chains and two phosphate groups, is the strongest known TLR4 ligand, and lipid A modifications can weaken or abolish TLR4 signalling and change the nature of the downstream cytokine profile (see below) 50–53 .”
Gujrati, V., Kim, S., Kim, S.-H., Min, J. J., Choy, H. E., Kim, S. C., & Jon, S. (2014) · ACS Nano · doi:10.1021/nn405724x · Cited by 543
Bacterial strategies for overcoming host innate and adaptive immune responses
Hornef, M. W., Wick, M. J., Rhen, M., & Normark, S. (2002) · Nature Immunology · doi:10.1038/ni1102-1033 · Cited by 510
Darveau, R. P., Pham, T.-T. T., Lemley, K., Reife, R. A., Bainbridge, B. W., Coats, S. R., Howald, W. N., Way, S. S., & Hajjar, A. M. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5041-5051.2004 · Cited by 507
Self-citationContribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders
Chopyk, D. M., & Grakoui, A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.04.077 · Cited by 490
Krishnegowda, G., Hajjar, A. M., Zhu, J., Douglass, E. J., Uematsu, S., Akira, S., Woods, A. S., & Gowda, D. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413541200 · Cited by 485
Self-citationCystic fibrosis: a mucosal immunodeficiency syndrome
Cohen, T. S., & Prince, A. (2012) · Nature Medicine · doi:10.1038/nm.2715 · Cited by 484
The endotoxin hypothesis of neurodegeneration
Brown, G. C. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1564-7 · Cited by 457
Ryu, J.-K., Kim, S. J., Rah, S.-H., Kang, J. I., Jung, H. E., Lee, D., Lee, H. K., Lee, J.-O., Park, B. S., Yoon, T.-Y., et al. (2017) · Immunity · doi:10.1016/j.immuni.2016.11.007 · Cited by 435
Smith, M. F., Mitchell, A., Li, G., Ding, S., Fitzmaurice, A. M., Ryan, K., Crowe, S., & Goldberg, J. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305536200 · Cited by 424
Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
Hauser, A. R., Jain, M., Bar-Meir, M., & McColley, S. A. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-10 · Cited by 411
Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response
Montminy, S. W., Khan, N., McGrath, S., Walkowicz, M. J., Sharp, F., Conlon, J. E., Fukase, K., Kusumoto, S., Sweet, C., Miyake, K., et al. (2006) · Nature Immunology · doi:10.1038/ni1386 · Cited by 408
TOLL-like receptors linking innate and adaptive immune response
Werling, D., & Jungi, T. W. (2003) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(02)00228-3 · Cited by 404
Bordetella pertussis pathogenesis: current and future challenges
Melvin, J. A., Scheller, E. V., Miller, J. F., & Cotter, P. A. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3235 · Cited by 363
Targeting mechanisms of Pseudomonas aeruginosa pathogenesis
Kipnis, E., Sawa, T., & Wiener-Kronish, J. (2006) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2005.10.007 · Cited by 353
Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2
Ohto, U., Fukase, K., Miyake, K., & Shimizu, T. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201193109 · Cited by 352
Vanderpool, C., Yan, F., & Polk, B. D. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20525 · Cited by 340
The immunobiology of the TLR9 subfamily
Wagner, H. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.04.011 · Cited by 341
Innate recognition of lipopolysaccharide by Toll-like receptor 4–MD-2
Miyake, K. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.02.009 · Cited by 335
Caesar, R., Reigstad, C. S., Bäckhed, H. K., Reinhardt, C., Ketonen, M., Östergren Lundén, G., Cani, P. D., & Bäckhed, F. (2012) · Gut · doi:10.1136/gutjnl-2011-301689 · Cited by 330
Review: Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa
King, J. D., Kocíncová, D., Westman, E. L., & Lam, J. S. (2009) · Innate Immunity · doi:10.1177/1753425909106436 · Cited by 312
Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens
Rosenberger, C. M., & Finlay, B. B. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1104 · Cited by 303
Genetic and Functional Diversity of Pseudomonas aeruginosa Lipopolysaccharide
Lam, J. S., Taylor, V. L., Islam, S. T., Hao, Y., & Kocíncová, D. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00118 · Cited by 298
Pseudomonas aeruginosa activates caspase 1 through Ipaf
Miao, E. A., Ernst, R. K., Dors, M., Mao, D. P., & Aderem, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712183105 · Cited by 297
Self-citationPotential Role of Endotoxin as a Proinflammatory Mediator of Atherosclerosis
Stoll, L. L., Denning, G. M., & Weintraub, N. L. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000147534.69062.dc · Cited by 288
Netea, M. G., Warris, A., Van der Meer, J. W. M., Fenton, M. J., Verver‐Janssen, T. J. G., Jacobs, L. E. H., Andresen, T., Verweij, P. E., & Kullberg, B. J. (2003) · The Journal of Infectious Diseases · doi:10.1086/376456 · Cited by 284
Recognition of lipid A variants by the TLR4-MD-2 receptor complex
Maeshima, N., & Fernandez, R. C. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00003 · Cited by 280
Variation matters: TLR structure and species-specific pathogen recognition
Werling, D., Jann, O. C., Offord, V., Glass, E. J., & Coffey, T. J. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.12.001 · Cited by 262
Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung
Hogardt, M., & Heesemann, J. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.08.008 · Cited by 257
PIER, G. (2007) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.03.012 · Cited by 253
Saitoh, S.-I. (2004) · International Immunology · doi:10.1093/intimm/dxh097 · Cited by 236
Role of Innate Immunity in Helicobacter pylori-Induced Gastric Malignancy
Peek, R. M., Fiske, C., & Wilson, K. T. (2010) · Physiological Reviews · doi:10.1152/physrev.00039.2009 · Cited by 230
“However, Mandell et al. (165) determined that while H. pyloriderived LPS stimulated TLR4, only TLR2 responded to intact bacteria.”
InfluentialChronic immune response dysregulation in MDS pathogenesis
Barreyro, L., Chlon, T. M., & Starczynowski, D. T. (2018) · Blood · doi:10.1182/blood-2018-03-784116 · Cited by 226
Chadha, J., Harjai, K., & Chhibber, S. (2022) · Environmental Microbiology · doi:10.1111/1462-2920.15784 · Cited by 180
Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modifications
Bäckhed, F., Normark, S., Schweda, E. K. H., Oscarson, S., & Richter-Dahlfors, A. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00207-7 · Cited by 177
Percival, S. L., Hill, K. E., Malic, S., Thomas, D. W., & Williams, D. W. (2011) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2010.00651.x · Cited by 173
Hajjar, A. M., Harvey, M. D., Shaffer, S. A., Goodlett, D. R., Sjöstedt, A., Edebro, H., Forsman, M., Byström, M., Pelletier, M., Wilson, C. B., et al. (2006) · Infection and Immunity · doi:10.1128/iai.00934-06 · Cited by 164
“96-well plates the day before transfection (19).”
Self-citationCoats, S. R., Reife, R. A., Bainbridge, B. W., Pham, T.-T. T., & Darveau, R. P. (2003) · Infection and Immunity · doi:10.1128/iai.71.12.6799-6807.2003 · Cited by 138
Long, L., Deng, Y., Yao, F., Guan, D., Feng, Y., Jiang, H., Li, X., Hu, P., Lu, X., Wang, H., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.015 · Cited by 127
Coats, S. R., Do, C. T., Karimi-Naser, L. M., Braham, P. H., & Darveau, R. P. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00859.x · Cited by 65
Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses
Sardar, P., Beresford-Jones, B. S., Xia, W., Shabana, O., Suyama, S., Ramos, R. J. F., Soderholm, A. T., Tourlomousis, P., Kuo, P., Evans, A. C., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-01930-y · Cited by 49
“7b), and although the LPS response between human and mouse TLR4/MD2 has been shown to differ 8 , similar effects on cytokine secretion (as a proxy of NF-kB activation) were also observed in a mouse macrophage cell line (Extended Data Fig.”
InfluentialRossetti, P., Trollmann, M. F. W., Wichmann, C., Gutsmann, T., Eggeling, C., & Böckmann, R. A. (2026) · Small · doi:10.1002/smll.202411476 · Cited by 25
Metadata
- Authors
- Hajjar, A. M., Ernst, R. K., Tsai, J. H., Wilson, C. B., & Miller, S. I.
- Affiliations
- University of Washington (US)
- Corresponding author
- Wilson, Christopher B.
- Miller, Samuel I.
- Venue
- Nature Immunology
- Published
- 2002-03-25
- Volume
- 3
- Issue
- 4
- Pages
- 354-359
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2078895028
- Cited by
- 579
- References
- 36
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 8 · 2023: 19 · 2022: 20 · 2021: 25 · 2020: 19 · 2019: 15 · 2018: 20 · 2017: 19 · 2016: 23 · 2015: 17 · 2014: 38 · 2013: 27 · 2012: 21
- FWCI
- 11.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cystic Fibrosis Foundation
- National Heart, Lung, and Blood Institute (R01HL069503, R01HL065898, HL65898, HL 69503)
- National Institute of Allergy and Infectious Diseases (AI 47938, R01AI047938)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Keywords
- TLR4, lipopolysaccharide, Pseudomonas aeruginosa, MD-2, cystic fibrosis, innate immunity, host adaptation, lipid A, paclitaxel, hypervariable region, host-bacteria interactions
- MeSH terms
- Animals, Antigens, Surface, Binding Sites, Carbohydrate Sequence, Cell Differentiation, Cell Line, Humans, Infant, Lipid A, Membrane Glycoproteins, Molecular Sequence Data, Pseudomonas aeruginosa, Receptors, Cell Surface, Drosophila Proteins, Toll-Like Receptors, Toll-Like Receptor 4, Lymphocyte Antigen 96, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.